These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28893110)

  • 21. Clinical radioimmunotherapy.
    Knox SJ; Meredith RF
    Semin Radiat Oncol; 2000 Apr; 10(2):73-93. PubMed ID: 10727597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Status of radioimmunotherapy in the new millennium.
    Imam SK
    Cancer Biother Radiopharm; 2001 Jun; 16(3):237-56. PubMed ID: 11471488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. General overview of radioimmunotherapy of solid tumors.
    Navarro-Teulon I; Lozza C; Pèlegrin A; Vivès E; Pouget JP
    Immunotherapy; 2013 May; 5(5):467-87. PubMed ID: 23638743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B7-H3-targeted Radioimmunotherapy of Human Cancer.
    Kasten BB; Ferrone S; Zinn KR; Buchsbaum DJ
    Curr Med Chem; 2020; 27(24):4016-4038. PubMed ID: 30836909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunotherapy of non-Hodgkin's lymphoma: molecular targeting and novel agents.
    Pauwels EK; Erba P
    Drug News Perspect; 2007 Mar; 20(2):87-93. PubMed ID: 17440631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods.
    Sharkey RM; Karacay H; Cardillo TM; Chang CH; McBride WJ; Rossi EA; Horak ID; Goldenberg DM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7109s-7121s. PubMed ID: 16203810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunotherapy with alpha-particle emitting radionuclides.
    Zalutsky MR; Pozzi OR
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmunodetection and therapy of breast cancer.
    DeNardo SJ
    Semin Nucl Med; 2005 Apr; 35(2):143-51. PubMed ID: 15765377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
    Sharkey RM; Goldenberg DM
    J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-based targeted radiation to pediatric tumors.
    Modak S; Cheung NK
    J Nucl Med; 2005 Jan; 46 Suppl 1():157S-63S. PubMed ID: 15653664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake, internalization and nuclear translocation of radioimmunotherapeutic agents.
    Hillyar CR; Cornelissen B; Vallis KA
    Ther Deliv; 2014 Mar; 5(3):319-35. PubMed ID: 24592956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Status of α-emitter Radioimmunoconjugates for Targeted Therapy.
    Mobina R; Vaez Alaei AR; Yousefnia H
    Curr Radiopharm; 2023; 16(2):85-94. PubMed ID: 36627787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing radioimmunoconjugate delivery in the treatment of solid tumor.
    Huang CY; Pourgholami MH; Allen BJ
    Cancer Treat Rev; 2012 Nov; 38(7):854-60. PubMed ID: 22226242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The promise of targeted {alpha}-particle therapy.
    Mulford DA; Scheinberg DA; Jurcic JG
    J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretargeting: A Path Forward for Radioimmunotherapy.
    Cheal SM; Chung SK; Vaughn BA; Cheung NV; Larson SM
    J Nucl Med; 2022 Sep; 63(9):1302-1315. PubMed ID: 36215514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal timing of administration of hyperthermia in combined radioimmunotherapy.
    Kinuya S; Yokoyama K; Hiramatsu T; Konishi S; Watanabe N; Shuke N; Aburano T; Bunko H; Michigishi T; Tonami N
    Cancer Biother Radiopharm; 2000 Aug; 15(4):373-9. PubMed ID: 11041022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.
    Dadachova E; Howell RW; Bryan RA; Frenkel A; Nosanchuk JD; Casadevall A
    J Nucl Med; 2004 Feb; 45(2):313-20. PubMed ID: 14960655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Where do we stand with radioimmunotherapy for acute myeloid leukemia?
    Walter RB
    Expert Opin Biol Ther; 2022 May; 22(5):555-561. PubMed ID: 35350938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New approaches for imaging and therapy of solid cancer.
    Sollini M; Boni R; Traino AC; Lazzeri E; Pasqualetti F; Modeo L; Mariani G; Petrini M; Erba PA
    Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):168-83. PubMed ID: 25693421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein targeting constructs in alpha therapy.
    Olafsen T; Elgqvist J; Wu AM
    Curr Radiopharm; 2011 Jul; 4(3):197-213. PubMed ID: 22201709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.